🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
90 Servings
Other Combinations Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Bacopa monniera leaf extract
100 mg
📊 Market median: 0.15mg (41 products)
Median 0.15mg This product: 1.5mg
📊 Market median: 300.0mg (122 products) 📚 22 studies (Tier A: 0, B: 7)
This product: 125mg
Vinpocetine
10 mg

Other Ingredients

Microcrystalline Cellulose Kosher Gelatin Titanium Oxide

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (94% of products) Nutrient (8% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

RECOMMENDATIONS: As an adult dietary supplement, take 1 capsule two to three times daily with meals.

⚠️ Warnings & Precautions

Use only under the advice of your physician if you are pregnant or nursing a baby, taking prescription medication or have a medical condition.

Keep out of the reach of children.

Additional Information

Mind Focusing... Intelligence Stimulating... Thought Provoking... Neuro Clarifying... Mental Clarifying... Brain Enhancing...

Neuro Charging

Mental Optimizer

CEREBRO

Product Details

DSLD Entry Date 2014-06-25
Product Type Other Combinations
Form Capsule
Brand Syntrax
DSLD ID 34766
Data Updated 2026-04-11

Research Evidence

2 Research Sources
64 Avg Quality Score
2 Cochrane Review
B Huperzine A for vascular dementia.
Cochrane Review The Cochrane database of systematic reviews
B Huperzine A for mild cognitive impairment.
Cochrane Review The Cochrane database of systematic reviews
View all evidence for Huperzine A →

Compare Similar Products

View all Huperzine A products →